Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia.
Saved in:
| Title: | Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia. |
|---|---|
| Authors: | Sonneveld P; Department of Hematology, Cancer Center, University Hospital Rotterdam Dijkzigt Room L407, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. sonneveld@haed.azr.nl, Burnett A, Vossebeld P, Ben-Am M, Rosenkranz G, Pfister C, Verhoef G, Dekker A, Ossenkoppele G, Ferrant C, Yin L, Gratwohl A, Kovacsovics T, Vellenga E, Capdeville R, Löwenberg B |
| Source: | The hematology journal : the official journal of the European Haematology Association [Hematol J] 2000; Vol. 1 (6), pp. 411-21. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase I; Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 100965523 Publication Model: Print Cited Medium: Print ISSN: 1466-4860 (Print) Linking ISSN: 14664860 NLM ISO Abbreviation: Hematol J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
